Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer

Barbara E. Kahn(University of Kentucky), Natasha Kyprianou(University of Kentucky)

International Journal of Biological Sciences

January 1, 2014

10.7150/ijbs.8671

Cited by 110

Related Papers

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

|Cancer Research|2010|350

Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells

|PLoS ONE|2014|35

Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis

|Endocrinology|2017|28

Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells

|Oncotarget|2017|26